Treatment of lung cancer
209 results
101 - 200
Concurrent chemoradiotherapy in non-small cell lung cancer: Cochrane systematic review- Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases: Cochrane systematic review
- Cisplatin versus carboplatin in combination with third‐generation drugs for advanced non‐small cell lung cancer
- Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients
- Short term benefits for laparoscopic colorectal resection
- Intermittent versus continuous androgen suppression for prostatic cancer
- Gefitinib for advanced non-small cell lung cancer: Cochrane systematic review
- Chemotherapy for brain metastases from small cell lung cancer: Cochrane systematic review
- Adjuvant chemotherapy for resected early-stage non-small cell lung cancer: Cochrane systematic review
- Antibody induction therapy for lung transplant recipients
- Platinum versus non‐platinum chemotherapy regimens for small cell lung cancer
- Pemetrexed disodium in combination with cisplatin versus other cytotoxic agents or supportive care for the treatment of malignant pleural mesothelioma
- Anticoagulation for perioperative thromboprophylaxis in people with cancer
- Cannabis‐based medicines and medical cannabis for adults with cancer pain
- Interventions for the management of malignant pleural effusions: a network meta‐analysis
- Anticoagulation for the long‐term treatment of venous thromboembolism in people with cancer
- Immunotherapy (excluding checkpoint inhibitors) for stage I to III non‐small cell lung cancer treated with surgery or radiotherapy with curative intent
- Antithrombotic therapy for ambulatory patients with multiple myeloma receiving immunomodulatory agents
- Anticoagulation for the initial treatment of venous thromboembolism in people with cancer
- Cardiovascular training versus resistance training for fatigue in people with cancer
- Antibiotics for preventing lower respiratory tract infections in high-risk children aged 12 years and under: Cochrane systematic review
- Pharmacological treatments for fatigue associated with palliative care: Cochrane systematic review
- Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy: Cochrane systematic review
- Radiotherapy for early breast cancer: Cochrane systematic review
- Second‐line chemotherapy for non‐small cell lung cancer
- Anaesthetic techniques for risk of malignant tumour recurrence
- Prophylactic antibiotics or G(M)‐CSF for the prevention of infections and improvement of survival in cancer patients receiving myelotoxic chemotherapy
- Antidepressants for depression in medical illness: Cochrane systematic review
- Platinum‐containing regimens for triple‐negative metastatic breast cancer
- Chemotherapy with cetuximab versus chemotherapy alone for chemotherapy-naive advanced non-small cell lung cancer: Cochrane systematic review
- Chemotherapy for advanced non‐small cell lung cancer in the elderly population
- Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases: Cochrane systematic review
- Chemotherapy versus best supportive care for extensive small cell lung cancer: Cochrane systematic review
- Percutaneous ethanol injection for liver metastases
- Alemtuzumab for patients with chronic lymphocytic leukaemia: Cochrane systematic review
- PET‐CT for assessing mediastinal lymph node involvement in patients with suspected resectable non‐small cell lung cancer
- Immunotherapy for advanced renal cell cancer: Cochrane systematic review
- Platinum‐containing regimens for metastatic breast cancer
- Mindfulness‐based stress reduction for women diagnosed with breast cancer
- Telephone interventions for symptom management in adults with cancer
- Antibiotic prophylaxis for preventing post solid organ transplant tuberculosis
- Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer
- Epidermal growth factor receptor blockers for the treatment of ovarian cancer
- Granulocyte-Colony Stimulating Factor (G-CSF) as an adjunct to antibiotics in the treatment of pneumonia in adults: Cochrane systematic review
- Microwave coagulation for liver metastases
- Fluorine‐18‐fluorodeoxyglucose (FDG) positron emission tomography (PET) computed tomography (CT) for the detection of bone, lung, and lymph node metastases in rhabdomyosarcoma
- Cyclophosphamide for connective tissue disease–associated interstitial lung disease
- High‐dose chemotherapy followed by autologous haematopoietic cell transplantation for children, adolescents, and young adults with primary metastatic Ewing sarcoma
- Targeted therapy for advanced renal cell carcinoma
- Nivolumab for adults with Hodgkin's lymphoma (a rapid review using the software RobotReviewer)
- Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism
- Antifibrinolytic therapy to reduce haemoptysis from any cause
- Interventions for fatigue and weight loss in adults with advanced progressive illness
- Interventions for preventing neuropathy caused by cisplatin and related compounds: Cochrane systematic review
- Screening for prostate cancer
- Neuromuscular electrical stimulation for muscle weakness in adults with advanced disease
- Tailored or adapted interventions for adults with chronic obstructive pulmonary disease and at least one other long‐term condition: a mixed methods review
- Single or combined immune checkpoint inhibitors compared to first‐line platinum‐based chemotherapy with or without bevacizumab for people with advanced non‐small cell lung cancer
- Interventions for promoting habitual exercise in people living with and beyond cancer
- Systematic screening and assessment of psychosocial well‐being and care needs of people with cancer
- Galactomannan detection in broncho‐alveolar lavage fluid for invasive aspergillosis in immunocompromised patients
- Glucocorticoid with cyclophosphamide for oral paraquat poisoning
- Golimumab for rheumatoid arthritis: Cochrane systematic review
- Early palliative care for adults with advanced cancer
- Exercise for cancer cachexia in adults
- Neuromuscular electrical stimulation for the prevention of venous thromboembolism
- Positioning and spinal bracing for pain relief in metastatic spinal cord compression in adults
- Chemotherapy for advanced gastric cancer
- Dehydroepiandrosterone for systemic lupus erythematosus
- Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial treatment of venous thromboembolism
- Treatment for Lambert‐Eaton myasthenic syndrome
- Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of deep vein thrombosis
- Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of pulmonary embolism
- Antioxidant vitamin and mineral supplements for preventing age‐related macular degeneration
- Methods to decrease blood loss during liver resection: a network meta‐analysis
- Long‐term hormone therapy for perimenopausal and postmenopausal women
- Exercise interventions for adults after liver transplantation
- Radical multimodality therapy for malignant pleural mesothelioma
- Interventions for tobacco cessation delivered by dental professionals
- Anti‐epidermal growth factor receptor therapy for glioblastoma in adults
- Graduated compression stockings for prevention of deep vein thrombosis